International Clinical Trial: A multicenter, open-label, randomized controlled trial of tirofiban in the treatment of acute ischemic stroke with blinded endpoint assessment

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125063) titled 'A multicenter, open-label, randomized controlled trial of tirofiban in the treatment of acute ischemic stroke with blinded endpoint assessment' on May 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated Hospital of Army Medical University, PLA

Condition: acute ischemic stroke

Intervention: Experimental group:Randomized to receive tirofiban with loading dose: 0.4 µg/kg/min intravenous micropump tirofiban for 30 minutes, and then continue at a rate of 0.1 µg/kg/min for 24 hours. Tirofiban hydrochloride injection was discontinued after a total of 24 hour...